Kuo‐Liang Wei
- Hepatology top 5%
- Hepatitis C virus research 15
-
- Liver Disease Diagnosis and Treatment 11
- Hepatitis B Virus Studies 7
-
- Epigenetics and DNA Methylation 4
- Cancer-related gene regulation 4
-
- Systemic Lupus Erythematosus Research 4
-
- HIV/AIDS drug development and treatment 4
-
- Helicobacter pylori-related gastroenterology studies 3
- Co-authors
- Shui‐Yi TungWei‐Ming ChenYung‐Yu HsiehTe‐Sheng ChangCheng-Shyong WuHuang‐Wei XuPey‐Jium ChangCheng‐Shyong Wu
- Partner nations
- TaiwanUnited StatesHong Kong
In The Last Decade
Kuo‐Liang Wei
33 papers receiving 431 citations
Peers
Comparison fields: 5 of 75
- Hepatology 155
- Geriatrics and Gerontology 22
- Epidemiology 182
- Cancer Research 40
- Pharmacology 23
Countries citing papers authored by Kuo‐Liang Wei
This map shows the geographic impact of Kuo‐Liang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Liang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Liang Wei more than expected).
Fields of papers citing papers by Kuo‐Liang Wei
This network shows the impact of papers produced by Kuo‐Liang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Liang Wei. The network helps show where Kuo‐Liang Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kuo‐Liang Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 8 | |
| 4 | 2021 | 9 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 37 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 12 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 0 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 10 | |
| 14 | 2016 | 27 | |
| 15 | 2016 | 57 | |
| 16 | 2016 | 14 | |
| 17 | 2015 | 10 | |
| 18 | 2015 | 45 | |
| 19 | 2012 | 4 | |
| 20 | 2007 | 3 |
About Kuo‐Liang Wei
Kuo‐Liang Wei is a scholar working on Hepatology, Gastroenterology and Epidemiology, having authored 34 papers that have together received 438 indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (7 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related gene regulation (4 papers), Systemic Lupus Erythematosus Research (4 papers), HIV/AIDS drug development and treatment (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). The work is most often cited by research in Hepatology (155 citations), Geriatrics and Gerontology (22 citations) and Epidemiology (182 citations). Kuo‐Liang Wei has collaborated with scholars based in Taiwan, United States and Hong Kong. Frequent co-authors include Shui‐Yi Tung, Wei‐Ming Chen, Yung‐Yu Hsieh, Te‐Sheng Chang, Cheng-Shyong Wu, Huang‐Wei Xu, Pey‐Jium Chang, Cheng‐Shyong Wu, Chia‐Hao Chang and Yung‐Chien Hsu. Their work appears in journals such as Gastroenterology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.